1. Blockade of the fractalkine–CX3CR1 axis ameliorates experimental colitis by dislodging venous crawling monocytes. (19th April 2019) Authors: Kuboi, Yoshikazu; Nishimura, Miyuki; Ikeda, Wataru; Nakatani, Tomoya; Seki, Yukie; Yamaura, Yui; Ogawa, Kana; Hamaguchi, Akiko; Muramoto, Kenzo; Mizuno, Keiko; Ogasawara, Hideaki; Yamauchi, Toshihiko; Yasuda, Nobuyuki; Onodera, Hiroshi; Imai, Toshio Journal: International immunology Issue: Volume 31:Number 5(2019) Page Start: 357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibition of the Progression of Skin Inflammation, Fibrosis, and Vascular Injury by Blockade of the CX3CL1/CX3CR1 Pathway in Experimental Mouse Models of Systemic Sclerosis. Issue 11 (11th September 2019) Authors: Luong, Vu H.; Utsunomiya, Akira; Chino, Takenao; Doanh, Le H.; Matsushita, Takashi; Obara, Takashi; Kuboi, Yoshikazu; Ishii, Naoto; Machinaga, Akihito; Ogasawara, Hideaki; Ikeda, Wataru; Kawano, Tetsu; Imai, Toshio; Oyama, Noritaka; Hasegawa, Minoru Journal: Arthritis & rheumatology Issue: Volume 71:Issue 11(2019) Page Start: 1923 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗